This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Oncology Professional Care Show

If you would like more information on oncology, please refer to the NHS website.

Visit the NHS website?

Sidebar CTAs

The value of prehabilitation and collaborative partnerships in optimising cancer care

Loading

The value of prehabilitation and collaborative partnerships in optimising cancer care

24 May 2022
Advanced Cancer Treatments
The value of prehabilitation and collaborative partnerships in optimising cancer care

Rapid innovation in oncology makes it vital for healthcare services to meet the ever-changing needs of patients. As such, BMS and Macmillan recognise the value of strategic partnership, working together to redesign the services of today to improve patient outcomes tomorrow. Prehabilitation is a programme of holistic support which helps prepare patients for their treatments. It is the first stage of cancer rehabilitation, and includes targeted interventions to improve patients’ physical and psychological wellbeing.

NO-GB-2200106 | April 2022

Speakers
Jagtar Dhanda, Policy, Advocacy and Government Affairs Manager - Bristol Myers Squibb
Jamie Kichenbrand, Head of Innovation Commercial Partnerships - Macmillan Cancer Support
Jeremy Pelton, National Partnership Manager - Bristol Myers Squibb